These are the top analyst calls of upgrades, downgrades, and initiations we have seen from Wall St. research calls this Tuesday morning.
AK Steel Holding Corp. (NYSE: AKS) cut to Sell at UBS.
Amphenol Corp. (NYSE: APH) cut to Neutral at BofA/ML.
Chesapeake Energy Corp. (NYSE: CHK) maintained Hold at Argus.
GlaxoSmithKline (NYSE: GSK) cut to Neutral at UBS.
Globus Medical Inc. (NYSE: GMED) started as Buy at Goldman Sachs, started as Buy at Canaccord Genuity, started as Outperform at Oppenheimer and started as Buy at BofA/ML.
IAC/InterActiveCorp. (NASDAQ: IACI) reiterated Buy with $62 target at Canaccord Genuity.
Kenexa Corp. (NYSE: KNXA) cut to Neutral at Credit Suisse.
M&T Bank Corp. (NYSE: MTB) maintained Neutral but raised target to $102 from $96 at Credit Suisse.
Pharmacyclics Inc. (NASDAQ: PCYC) cut to Sector Perform at RBC.
VMware Inc. (NYSE: VMW) reiterated Buy with $120 price target at BofA/ML.
Argus has maintained a Buy rating on Dell Inc. (NASDAQ: DELL) with an $18 price target; Hewlett-Packard Co. (NYSE: HPQ) reiterated Buy but cut target to $25 from $30. The problem is that Argus calls Dell in a painful transition away from PCs and said difficulties persist at HP while a deep value story is there.
JON C. OGG